Nature 380:435439 Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS et al (2003) The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis
503A refers to a section of the federal Food, Drug & Cosmetic Act that lets compounding pharmacies make custom medications for individual patients using bulk ingredients on an FDA-approved list
For research inquiries, please review the educational content on each product page before proceeding to the catalog.
Fight blemishes
Myoglobinuria, the traditional hallmark of this disease was not present in 21% patients in one study [48]
These results indicated that individual members of the GhGPX gene family respond differentially against abiotic stress and plant hormones, and these findings may provide a clue to explain the differential regulation of transcripts under stress conditions